Biosimilars

ARTICLES

According to a report by Elsevier's BusinessIntelligence, UnitedHealthcare has announced that pharmacies that are participating in its Designated Specialty Pharmacy network will no longer redeem manufacturer-sponsored coupons as an offset to member cost-sharing payments for 6 specialty drugs beginning January 1, 2013.
With so many factors at play, it can be difficult to assess the true impact of generic drugs on healthcare costs.
As the FDA continues to work on the biosimilars approval process, there are growing concerns that a true cost-savings can't be realized.

MULTIMEDIA



Feature

$vacMongoViewPlus$